Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease

Citation
de Andrade, P., Mantoani, S. P., Gonçalves Nunes, P. S., Magadán, C. R., Pérez, C., Xavier, D. J., Hojo, E. T. S., Campillo, N. E., Martínez, A., & Carvalho, I. (2019). Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer’s disease. Bioorganic & Medicinal Chemistry, 27(6), 931–943. https://doi.org/10.1016/j.bmc.2018.12.030
DOI:
DOI: 10.1016/j.bmc.2018.12.030
Year of publication:
2019